What do you think about the article, “Medical experts rethink routine screenings for breast and prostate cancer”?
A startling new analysis concludes that routine screenings for breast and prostate cancer miss the most deadly forms of the disease — and may expose healthy patients to risky, expensive and needless treatments. The nation’s long-standing “War on Cancer” is built on the assumption that early and widespread cancer screening saves lives. The new assessment, published in the prestigious Journal of the American Medical Association, takes a tough look at whether modern medicine has overpromised its benefits. Although screening does provide some benefit, it is not nearly what had been hoped — and carries a significant cost, argue experts at the University of California-San Francisco and University of Texas in today’s edition of the journal. Routine screening is critical to prevent deaths from cervical and colon cancer, they stress, but screening for breast and prostate cancers has not significantly reduced the death toll, and can lead to harm. That’s because tests detect slow-growing and indo
A startling new analysis concludes that routine screenings for breast and prostate cancer miss the most deadly forms of the disease — and may expose healthy patients to risky, expensive and needless treatments. The nation’s long-standing “War on Cancer” is built on the assumption that early and widespread cancer screening saves lives. The new assessment, published in the prestigious Journal of the American Medical Association, takes a tough look at whether modern medicine has overpromised its benefits. Although screening does provide some benefit, it is not nearly what had been hoped — and carries a significant cost, argue experts at the University of California-San Francisco and University of Texas in today’s edition of the journal. Routine screening is critical to prevent deaths from cervical and colon cancer, they stress, but screening for breast and prostate cancers has not significantly reduced the death toll, and can lead to harm. That’s because tests detect slow-growing and indo
A startling new analysis concludes that routine screenings for breast and prostate cancer miss the most deadly forms of the disease — and may expose healthy patients to risky, expensive and needless treatments. The nation’s long-standing “War on Cancer” is built on the assumption that early and widespread cancer screening saves lives. The new assessment, published in the prestigious Journal of the American Medical Association, takes a tough look at whether modern medicine has overpromised its benefits. Although screening does provide some benefit, it is not nearly what had been hoped — and carries a significant cost, argue experts at the University of California-San Francisco and University of Texas in today’s edition of the journal. Routine screening is critical to prevent deaths from cervical and colon cancer, they stress, but screening for breast and prostate cancers has not significantly reduced the death toll, and can lead to harm.
